Insider · CIK 0001433991

JOSEPH TAMARA L

Reports to the SEC for 4 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001433991

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-02	SPROSpero Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−30.9K sh	$1.37	−$42.3K	531,615
2024-02-01	SPROSpero Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+240K sh	—	—	562,521
2023-08-28	SPROSpero Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−1,854 sh	$1.26	−$2,336.04	322,790
2023-02-02	SPROSpero Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−3,394 sh	$1.86	−$6,312.84	324,644
2023-02-01	SPROSpero Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+266K sh	—	—	328,038
2022-02-01	SPROSpero Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+38K sh	—	—	62,081
2022-02-01	SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+53.2K sh	—	—	53,190
2021-08-26	SPROSpero Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+24.1K sh	—	—	24,067
2020-12-02	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+75K sh	—	—	75,000
2020-05-25	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+80K sh	—	—	80,000
2020-01-31	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+56.3K sh	—	—	56,250
2019-08-19	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+130K sh	—	—	130,000
2017-01-18	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (Right to Buy)A Award	SVP, General Counsel	AAward	+120K sh	—	—	120,000
2015-12-31	INVIVO THERAPEUTICS HOLDINGS CORP.A Award	SVP, General Counsel	AAward	+1,599 sh	$6.12	+$9,785.88	17,027
2015-12-10	INVIVO THERAPEUTICS HOLDINGS CORP.STOCK OPTION (RIGHT TO BUY)A Award	SVP, General Counsel	AAward	+92K sh	—	—	92,040
2015-07-31	INVIVO THERAPEUTICS HOLDINGS CORP.STOCK OPTION (RIGHT TO BUY)A Award	SVP, General Counsel	AAward	+12.5K sh	—	—	12,500
2014-12-10	INVIVO THERAPEUTICS HOLDINGS CORP.A Award	SVP, General Counsel	AAward	+15.4K sh	—	—	15,428
2014-12-10	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (Right To Buy)A Award	SVP, General Counsel	AAward	+138K sh	—	—	137,500
2014-03-24	INVIVO THERAPEUTICS HOLDINGS CORP.STOCK OPTION (RIGHT TO BUY)A Award	SVP, General Counsel	AAward	+300K sh	—	—	300,000
2012-06-29	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+640 sh	$32.22	+$20.6K	17,571
2012-06-06	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+20K sh	$19.16	+$383K	39,059
2012-06-06	CUBIST PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−20K sh	$41.16	−$823K	19,059
2012-06-06	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−20K sh	—	—	80,000
2012-05-15	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+1,200 sh	—	—	19,059
2012-05-15	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−1,200 sh	—	—	1,200
2012-05-14	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+2,625 sh	—	—	17,859
2012-05-14	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−2,625 sh	—	—	5,250
2012-05-13	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+3,000 sh	—	—	15,234
2012-05-13	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−3,000 sh	—	—	9,000
2012-03-30	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+260 sh	$43.25	+$11.2K	12,234
2012-02-16	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP, GC & Secretary	AAward	+37.5K sh	—	—	37,500
2012-02-16	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, GC & Secretary	AAward	+6,000 sh	—	—	6,000
2011-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+1,142 sh	$18.60	+$21.2K	11,974
2011-05-15	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+1,200 sh	—	—	10,832
2011-05-15	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−1,200 sh	—	—	2,400
2011-05-14	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+2,625 sh	—	—	9,632
2011-05-14	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−2,625 sh	—	—	7,875
2011-05-13	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP, GC & Secretary	AAward	+75K sh	—	—	75,000
2011-05-13	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, GC & Secretary	AAward	+12K sh	—	—	12,000
2011-03-31	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+437 sh	$25.24	+$11K	7,007
2010-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+1,314 sh	$16.17	+$21.2K	6,552
2010-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+18 sh	$20.60	+$370.8	6,570
2010-05-15	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+1,200 sh	—	—	5,238
2010-05-15	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−1,200 sh	—	—	3,600
2010-05-14	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, GC & Secretary	AAward	+10.5K sh	—	—	10,500
2010-05-14	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP, GC & Secretary	AAward	+50K sh	—	—	50,000
2010-03-31	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+473 sh	$22.54	+$10.7K	4,038
2009-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+998 sh	$15.58	+$15.5K	3,437
2009-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP, GC & Secretary	JOther	+128 sh	$18.33	+$2,346.24	3,565
2009-05-15	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP, GC & Secretary	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Feb 54
JOSEPH TAMARA L0000950170-24-011494
SEC(opens sec.gov)
Aug 304
JOSEPH TAMARA L0000950170-23-045448
SEC(opens sec.gov)
Feb 34
JOSEPH TAMARA L0000899243-23-003946
SEC(opens sec.gov)
Feb 34
JOSEPH TAMARA L0000899243-22-004586
SEC(opens sec.gov)
Aug 304
JOSEPH TAMARA L0000899243-21-034500
SEC(opens sec.gov)
Dec 24
JOSEPH TAMARA L0000899243-20-032557
SEC(opens sec.gov)
May 274
JOSEPH TAMARA L0001209191-20-032487
SEC(opens sec.gov)
Feb 44
JOSEPH TAMARA L0001209191-20-006361
SEC(opens sec.gov)
Aug 204
JOSEPH TAMARA L0001209191-19-046918
SEC(opens sec.gov)
Jan 204
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-17-001105
SEC(opens sec.gov)
Jan 225
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-16-017959
SEC(opens sec.gov)
Dec 114
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-15-016171
SEC(opens sec.gov)
Aug 44
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-15-011684
SEC(opens sec.gov)
Dec 114
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-14-017964
SEC(opens sec.gov)
Mar 264
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-14-005846
SEC(opens sec.gov)
Jul 34
JOSEPH TAMARA L0001127602-12-021357
SEC(opens sec.gov)

Companies

Address

65 HAYDEN AVENUE

LEXINGTON, MA, 02421